Patents by Inventor Jo Ann JACKSON

Jo Ann JACKSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for detecting C1orf43 nucleic acid
    Patent number: 11920197
    Abstract: This disclosure provides oligomers, combinations of oligomers, compositions, kits, uses, and methods for detecting a C1orf43 nucleic acid, such as C1orf43 mRNA, such as human C1orf43 mRNA, in a sample.
    Type: Grant
    Filed: June 1, 2022
    Date of Patent: March 5, 2024
    Assignee: Gen-Probe Incorporated
    Inventors: Siobhán M. Miick, Paul M. Darby, Jo Ann Jackson, Damon Kittredge Getman
  • Compositions and Methods for Detecting or Quantifying Hepatitis C Virus
    Publication number: 20220389525
    Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis C virus (HCV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the 5? untranslated region of HCV and are configured to provide substantially equivalent quantification of different genotypes and variants of HCV.
    Type: Application
    Filed: June 27, 2022
    Publication date: December 8, 2022
    Applicant: Gen-Probe Incorporated
    Inventors: Siobhan Miick, Paul M. Darby, Jo Ann Jackson, Sheila M.J. Aubin
  • Compositions and Methods for Detecting C1orf43 Nucleic Acid
    Publication number: 20220307084
    Abstract: This disclosure provides oligomers, combinations of oligomers, compositions, kits, uses, and methods for detecting a C1orf43 nucleic acid, such as C1orf43 mRNA, such as human C1orf43 mRNA, in a sample.
    Type: Application
    Filed: June 1, 2022
    Publication date: September 29, 2022
    Applicant: Gen-Probe Incorporated
    Inventors: Siobhán M. Miick, Paul M. Darby, Jo Ann Jackson, Damon Kittredge Getman
  • Compositions and methods for detecting or quantifying hepatitis C virus
    Patent number: 11447835
    Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis C virus (HCV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the 5? untranslated region of HCV and are configured to provide substantially equivalent quantification of different genotypes and variants of HCV.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: September 20, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Siobhan Miick, Paul M. Darby, Jo Ann Jackson, Sheila M. J. Aubin
  • Compositions and methods for detecting C1orf43 nucleic acid
    Patent number: 11377688
    Abstract: This disclosure provides oligomers, combinations of oligomers, compositions, kits, uses, and methods for detecting a C1orf43 nucleic acid, such as C1orf43 mRNA, such as human C1orf43 mRNA, in a sample.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: July 5, 2022
    Assignee: Gen-Probe Incorporated
    Inventors: Siobhán M. Miick, Paul M. Darby, Jo Ann Jackson, Damon Kittredge Getman
  • COMPOSITIONS AND METHODS FOR AMPLIFYING, DETECTING OR QUANTIFYING HUMAN CYTOMEGALOVIRUS
    Publication number: 20220074002
    Abstract: Oligomer nucleotides, compositions, methods, kits, and uses are provided for detecting or quantifying a Human Cytomegalovirus virus 1 (CMV (human herpesvirus 5, HHV5) nucleic acid, e.g., using nucleic acid amplification and hybridization assays. Multiphase amplification of a CMV target sequence is also described. The oligomer nucleotides, compositions, methods, kits, and uses can be used to amplify and/or detect the UL56 gene of CMV.
    Type: Application
    Filed: August 21, 2019
    Publication date: March 10, 2022
    Inventors: Paul Darby, Siobhan Miick, Jo Ann Jackson, Hee Cheol Kim, Amber Hillius, Ankur Shah
  • Compositions and Methods for Detecting C1orf43 Nucleic Acid
    Publication number: 20200399696
    Abstract: This disclosure provides oligomers, combinations of oligomers, compositions, kits, uses, and methods for detecting a C1orf43 nucleic acid, such as C1orf43 mRNA, such as human C1orf43 mRNA, in a sample.
    Type: Application
    Filed: November 15, 2018
    Publication date: December 24, 2020
    Applicant: Gen-Probe Incorporated
    Inventors: Siobhán M. Miick, Paul M. Darby, Jo Ann Jackson, Damon Kittredge Getman
  • COMPOSITIONS AND METHODS FOR DETECTING OR QUANTIFYING HEPATITIS C VIRUS
    Publication number: 20180291474
    Abstract: This disclosure provides oligomers, compositions, and kits for detecting and quantifying Hepatitis C virus (HCV), including different genotypes and variants thereof, and related methods and uses. In some embodiments, oligomers target the 5? untranslated region of HCV and are configured to provide substantially equivalent quantification of different genotypes and variants of HCV.
    Type: Application
    Filed: October 18, 2017
    Publication date: October 11, 2018
    Inventors: Siobhan MIICK, Paul M. DARBY, Jo Ann JACKSON, Sheila M.J. AUBIN
  • COMPOSITIONS AND METHODS TO DETECT TMPRSS2/ERG TRANSCRIPT VARIANTS IN PROSTATE CANCER
    Publication number: 20100196903
    Abstract: Compositions and methods for detecting TMPRSS2/ERG transcript variants in prostate cancer are provided. The compositions and methods have utility in prostate cancer diagnosis.
    Type: Application
    Filed: January 18, 2010
    Publication date: August 5, 2010
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Paul M. DARBY, Siobhan M. MIICK, Kumar KASTURY, Jo Ann JACKSON